117 related articles for article (PubMed ID: 38783553)
1. The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures.
Mallama C; Karami S; Zhang D; Zhao Y; Yang Y; Woods C; Ding Y; Meyer T; McAninch J
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5793. PubMed ID: 38783553
[TBL] [Abstract][Full Text] [Related]
2. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.
Wu A; Phan C; Nguyen KC; Quindoy M; Lewis J; Apollonio DE
Clin Toxicol (Phila); 2021 Apr; 59(4):313-319. PubMed ID: 32840386
[TBL] [Abstract][Full Text] [Related]
3. The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths.
Karami S; Ajao A; Wong J; Zhang D; Meyer T; Ding Y; Secora A; Major JM; Gill R; Chai GP; Zhao Y; McAninch J
Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):735-751. PubMed ID: 36779261
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
[TBL] [Abstract][Full Text] [Related]
5. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
Haynes A; Kleinschmidt K; Forrester MB; Young A
Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
[TBL] [Abstract][Full Text] [Related]
6. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014.
Fischer LJ; Severtson SG; Gurrola MC; Iwanicki JL; Green JL; Dart RC
Subst Use Misuse; 2022; 57(7):1097-1103. PubMed ID: 35450512
[TBL] [Abstract][Full Text] [Related]
7. Has the rescheduling of hydrocodone changed ED prescribing practices?
Oehler EC; Day RL; Robinson DB; Brown LH
Am J Emerg Med; 2016 Dec; 34(12):2388-2391. PubMed ID: 27776785
[TBL] [Abstract][Full Text] [Related]
8. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
[TBL] [Abstract][Full Text] [Related]
9. Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone.
Chumpitazi CE; Rees CA; Camp EA; Bernhardt MB
J Emerg Med; 2017 Apr; 52(4):547-553. PubMed ID: 27727038
[TBL] [Abstract][Full Text] [Related]
10. Race and ethnicity: Not factors in the prescribing of hydrocodone and codeine-containing products in two pediatric emergency departments.
Rees CA; Bernhardt MB; Camp EA; Lin JS; Chumpitazi CE
J Opioid Manag; 2019; 15(3):229-233. PubMed ID: 31343724
[TBL] [Abstract][Full Text] [Related]
11. Drug Enforcement Agency 2014 Hydrocodone Rescheduling Rule and Opioid Dispensing after Surgery.
Neuman MD; Hennessy S; Small DS; Newcomb C; Gaskins L; Brensinger CM; Wijeysundera DN; Bateman BT; Wunsch H
Anesthesiology; 2020 May; 132(5):1151-1164. PubMed ID: 32101973
[TBL] [Abstract][Full Text] [Related]
12. Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
Usmani SA; Hollmann J; Goodin A; Hincapie-Castillo JM; Adkins LE; Ourhaan N; Oueini R; Bhagwandass H; Easey T; Vouri SM
J Am Pharm Assoc (2003); 2021; 61(2):e20-e44. PubMed ID: 33127312
[TBL] [Abstract][Full Text] [Related]
13. Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio.
Liu Y; Baker O; Schuur JD; Weiner SG
Pain Med; 2020 Sep; 21(9):1863-1870. PubMed ID: 31502638
[TBL] [Abstract][Full Text] [Related]
14. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center.
Schultz S; Chamberlain C; Vulcan M; Rana H; Patel B; Alexander JC
J Opioid Manag; 2016; 12(2):119-22. PubMed ID: 27194196
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Unintentional Exposures to Codeine and Hydrocodone Reported to Texas Poison Centers.
Day L; Kleinschmidt K; Forrester MB; Feng SY
J Emerg Med; 2016 May; 50(5):744-52. PubMed ID: 26899518
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
[TBL] [Abstract][Full Text] [Related]
17. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population.
Tran S; Lavitas P; Stevens K; Greenwood BC; Clements K; Alper CJ; Lenz K; Price M; Hydery T; Arnold JL; Takeshita M; Bacon R; Peristere JP; Jeffrey PL
J Manag Care Spec Pharm; 2017 May; 23(5):532-539. PubMed ID: 28448772
[TBL] [Abstract][Full Text] [Related]
18. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach.
Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat M; Sawant RV; Ferries E; Reeve K; Todd KH
Res Social Adm Pharm; 2017; 13(3):503-512. PubMed ID: 27567741
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
[TBL] [Abstract][Full Text] [Related]
20. Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences.
Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat MA; Varisco TJ; Pickard T; Reeve K; Todd KH
J Pain Palliat Care Pharmacother; 2019; 33(1-2):22-31. PubMed ID: 31454279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
